Ramsay (ASX:RHC) share price pushes higher on US$1.35bn proposal for Asian JV

Ramsay has received an offer for its joint venture…

| More on:
A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Ramsay has responded to speculation and confirmed that it has received an offer for its Asian joint venture.
  • IHH Healthcare Berhad has tabled a US$1.35 billion offer for the joint venture.
  • Ramsay has granted IHH with due dilligence.

The Ramsay Health Care Limited (ASX: RHC) share price is pushing higher on Tuesday.

In afternoon trade, the private hospital operator's shares are up 2% to $64.60.

Despite this gain, the Ramsay share price is still down 10% since the start of the year.

Why is the Ramsay share price pushing higher?

Investors have bidding the Ramsay share price higher today after the healthcare giant responded to media speculation relating to its Asian operations.

According to the release, Ramsay and Sime Darby Holdings have received a confidential, conditional, non-binding, indicative proposal from IHH Healthcare Berhad to acquire 100% of their 50:50 joint venture in Asia, Ramsay Sime Darby Health Care Sdn.

The release notes that under the indicative proposal, the conditional indicative enterprise value for Ramsay Sime Darby is MYR5,670 million (or US$1.35 billion) on a cash free, debt free basis.

Though, the indicative proposal remains subject to conditions including the completion of satisfactory due diligence and the negotiation and finalisation of a sale and purchase agreement.

What now?

Ramsay and its joint venture partner appear to have seen value in the offer from IHH Healthcare Berhad.

The release reveals that after reviewing the proposal, both Ramsay and Sime Darby Holdings have agreed to a period of exclusivity for four weeks when due diligence commences to allow IHH Healthcare Berhad to conduct due diligence and negotiate a sale and purchase agreement.

Though, management warns that discussions between Ramsay, Sime Darby Holdings and IHH Healthcare Berhad are preliminary and no agreement has been reached in relation to the indicative proposal. As such, there is no guarantee that an agreement will be reached in respect of the proposal or that a transaction will eventuate.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

a young woman holds her hand to her ear and leans sideways as if to listen to something that's surprising her as her eyes and her mouth are wide open.
Healthcare Shares

Down 15% since January, are Cochlear shares now a buy?

Let's see what analysts are saying about this blue chip.

Read more »

Green arrow with green stock prices symbolising a rising share price.
Healthcare Shares

Guess which popular ASX 200 stock is up nearly 60% in less than 2 months?

Investors who bought this ASX 200 stock in the recent dip have been strongly rewarded.

Read more »

A senior pharmacist talks to a customer at the counter in a shop.
Healthcare Shares

Are Sigma Healthcare shares a good buy now after the merger with Chemist Warehouse?

Sigma Healthcare shares have soared 154% in 12 months. Can this stellar run continue?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

Up 34% since April, ASX 300 healthcare stock lifts off again today on new milestone

The ASX 300 healthcare stock has been on a tear since hitting one-year lows in April.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Should I buy the dip on CSL shares?

A leading fund manager gives his verdict on the growth prospects for CSL shares.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Healthcare Shares

NIB shares have soared 24% this year. Does Macquarie expect this to continue?

Will this private health insurer continue to deliver big returns? Let's find out.

Read more »

Woman presenting financial report on large screen in conference room.
Healthcare Shares

Up nearly 30% in a year, should I buy Fisher & Paykel shares before its earnings result?

Will the ASX 200 healthcare stock continue to outperform?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL shares among most expensive on ASX. Is now a good time to buy?

Analysts predict CSL share price growth will keep on coming.

Read more »